vs
芝商所(CME)与亨斯迈(HUN)财务数据对比。点击上方公司名可切换其他公司
芝商所的季度营收约是亨斯迈的1.4倍($1.9B vs $1.4B),芝商所净利率更高(0.1% vs -7.1%,领先7.1%),芝商所同比增速更快(14.5% vs -6.7%),过去两年芝商所的营收复合增速更高(10.8% vs -4.0%)
芝商所是总部位于美国伊利诺伊州芝加哥的金融服务企业,为全球规模最大的金融衍生品交易所运营商,旗下拥有芝加哥商品交易所、芝加哥期货交易所、纽约商业交易所、纽约商品交易所等交易平台,覆盖农产品、货币、能源等品类交易,同时持有标普道琼斯指数27%的股权。
亨斯迈公司是总部位于美国得克萨斯州伍德兰兹的全球化化工巨头,面向消费端与工业客户生产、销售各类化工产品,主营聚氨酯、高性能材料及胶粘剂,客户覆盖宝马、通用电气、雪佛龙、宝洁、联合利华等知名品牌。目前公司在全球25个国家设有60余处生产、研发及运营基地,员工约7000人。
CME vs HUN — 直观对比
营收规模更大
CME
是对方的1.4倍
$1.4B
营收增速更快
CME
高出21.2%
-6.7%
净利率更高
CME
高出7.1%
-7.1%
两年增速更快
CME
近两年复合增速
-4.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.9B | $1.4B |
| 净利润 | $1.2M | $-96.0M |
| 毛利率 | — | 12.1% |
| 营业利润率 | 0.1% | -4.4% |
| 净利率 | 0.1% | -7.1% |
| 营收同比 | 14.5% | -6.7% |
| 净利润同比 | 20.7% | 31.9% |
| 每股收益(稀释后) | — | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CME
HUN
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.6B | $1.4B | ||
| Q3 25 | $1.5B | $1.5B | ||
| Q2 25 | $1.7B | $1.5B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.5B | $1.5B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.5B | $1.6B |
净利润
CME
HUN
| Q1 26 | $1.2M | — | ||
| Q4 25 | $1.2B | $-96.0M | ||
| Q3 25 | $908.0M | $-25.0M | ||
| Q2 25 | $1.0B | $-158.0M | ||
| Q1 25 | $956.2M | $-5.0M | ||
| Q4 24 | $874.6M | $-141.0M | ||
| Q3 24 | $912.8M | $-33.0M | ||
| Q2 24 | $883.2M | $22.0M |
毛利率
CME
HUN
| Q1 26 | — | — | ||
| Q4 25 | — | 12.1% | ||
| Q3 25 | — | 14.0% | ||
| Q2 25 | — | 12.5% | ||
| Q1 25 | — | 14.3% | ||
| Q4 24 | — | 12.9% | ||
| Q3 24 | — | 15.2% | ||
| Q2 24 | — | 15.4% |
营业利润率
CME
HUN
| Q1 26 | 0.1% | — | ||
| Q4 25 | 61.8% | -4.4% | ||
| Q3 25 | 63.3% | 0.4% | ||
| Q2 25 | 66.7% | -8.2% | ||
| Q1 25 | 67.5% | 3.0% | ||
| Q4 24 | 62.1% | -4.3% | ||
| Q3 24 | 64.6% | 2.7% | ||
| Q2 24 | 65.3% | 2.2% |
净利率
CME
HUN
| Q1 26 | 0.1% | — | ||
| Q4 25 | 71.7% | -7.1% | ||
| Q3 25 | 59.1% | -1.7% | ||
| Q2 25 | 60.6% | -10.8% | ||
| Q1 25 | 58.2% | -0.4% | ||
| Q4 24 | 57.3% | -9.7% | ||
| Q3 24 | 57.6% | -2.1% | ||
| Q2 24 | 57.6% | 1.4% |
每股收益(稀释后)
CME
HUN
| Q1 26 | — | — | ||
| Q4 25 | $3.24 | $-0.56 | ||
| Q3 25 | $2.49 | $-0.14 | ||
| Q2 25 | $2.81 | $-0.92 | ||
| Q1 25 | $2.62 | $-0.03 | ||
| Q4 24 | $2.40 | $-0.82 | ||
| Q3 24 | $2.50 | $-0.19 | ||
| Q2 24 | $2.42 | $0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $2.4B | $429.0M |
| 总债务越低越好 | $3.4B | $2.0B |
| 股东权益账面价值 | — | $2.8B |
| 总资产 | $202.0B | $7.0B |
| 负债/权益比越低杠杆越低 | — | 0.73× |
8季度趋势,按日历期对齐
现金及短期投资
CME
HUN
| Q1 26 | $2.4B | — | ||
| Q4 25 | $4.5B | $429.0M | ||
| Q3 25 | $2.6B | $468.0M | ||
| Q2 25 | $2.1B | $399.0M | ||
| Q1 25 | $1.5B | $334.0M | ||
| Q4 24 | $3.0B | $340.0M | ||
| Q3 24 | $2.4B | $330.0M | ||
| Q2 24 | $1.9B | $335.0M |
总债务
CME
HUN
| Q1 26 | $3.4B | — | ||
| Q4 25 | — | $2.0B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $1.9B |
股东权益
CME
HUN
| Q1 26 | — | — | ||
| Q4 25 | $28.7B | $2.8B | ||
| Q3 25 | $28.2B | $2.8B | ||
| Q2 25 | $27.7B | $2.8B | ||
| Q1 25 | $27.0B | $3.0B | ||
| Q4 24 | $26.5B | $3.0B | ||
| Q3 24 | $28.2B | $3.1B | ||
| Q2 24 | $27.6B | $3.1B |
总资产
CME
HUN
| Q1 26 | $202.0B | — | ||
| Q4 25 | $198.4B | $7.0B | ||
| Q3 25 | $187.1B | $7.1B | ||
| Q2 25 | $179.9B | $7.1B | ||
| Q1 25 | $157.8B | $7.2B | ||
| Q4 24 | $137.4B | $7.1B | ||
| Q3 24 | $137.8B | $7.3B | ||
| Q2 24 | $123.4B | $7.3B |
负债/权益比
CME
HUN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 0.73× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.62× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $76.0M |
| 自由现金流经营现金流 - 资本支出 | — | $19.0M |
| 自由现金流率自由现金流/营收 | — | 1.4% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $116.0M |
8季度趋势,按日历期对齐
经营现金流
CME
HUN
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $76.0M | ||
| Q3 25 | $968.1M | $196.0M | ||
| Q2 25 | $1.1B | $91.0M | ||
| Q1 25 | $1.1B | $-74.0M | ||
| Q4 24 | $1.0B | $153.0M | ||
| Q3 24 | $1.0B | $129.0M | ||
| Q2 24 | $776.9M | $46.0M |
自由现金流
CME
HUN
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $19.0M | ||
| Q3 25 | $949.7M | $153.0M | ||
| Q2 25 | $1.0B | $54.0M | ||
| Q1 25 | $1.1B | $-110.0M | ||
| Q4 24 | $991.7M | $102.0M | ||
| Q3 24 | $973.2M | $88.0M | ||
| Q2 24 | $758.7M | $-4.0M |
自由现金流率
CME
HUN
| Q1 26 | — | — | ||
| Q4 25 | 66.8% | 1.4% | ||
| Q3 25 | 61.8% | 10.5% | ||
| Q2 25 | 61.5% | 3.7% | ||
| Q1 25 | 67.1% | -7.8% | ||
| Q4 24 | 65.0% | 7.0% | ||
| Q3 24 | 61.4% | 5.7% | ||
| Q2 24 | 49.5% | -0.3% |
资本支出强度
CME
HUN
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 4.2% | ||
| Q3 25 | 1.2% | 2.9% | ||
| Q2 25 | 1.1% | 2.5% | ||
| Q1 25 | 0.9% | 2.6% | ||
| Q4 24 | 1.7% | 3.5% | ||
| Q3 24 | 1.9% | 2.7% | ||
| Q2 24 | 1.2% | 3.2% |
现金转化率
CME
HUN
| Q1 26 | — | — | ||
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.07× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.17× | — | ||
| Q4 24 | 1.16× | — | ||
| Q3 24 | 1.10× | — | ||
| Q2 24 | 0.88× | 2.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CME
暂无分部数据
HUN
| Diversified | $897.0M | 66% |
| Specialty | $231.0M | 17% |
| Performance Products | $113.0M | 8% |
| Advanced Materials | $61.0M | 5% |
| Related Party Customers | $19.0M | 1% |
| Other | $12.0M | 1% |